Glaukos
GKOS on XNYS, Glaukos Corporation
Measures activity, not value. Not investment advice.
Latest month (Mar 2026)
$169K
7.9× the 3-year median
Last 12 months
$233K
-57% vs the 12 months before
Sharp changes
0
federal obligations jump, first federal award, first award from a new federal agency
What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
USAspending.gov obligations by date. Dashed: 3-year median. Incomplete recent periods left out (91-day reporting lag).
See the numbers
| Month of Mar 2026: $169K |
| Month of Jan 2026: -$117K |
| Month of Aug 2025: $11K |
| Month of May 2025: $128K |
| Month of Apr 2025: $43K |
| Month of Jan 2025: $21K |
| Month of Sep 2024: $21K |
| Month of Aug 2024: $11K |
| Month of Jul 2024: $213K |
| Month of Jun 2024: $277K |
What the numbers say
- Federal obligations: $169K in March 2026, 7.9× the 3-year median; the most since Jul 2024.
- Federal obligations over 12 months: $31K, number 85 of 120 Health Care companies with data (median $214K).
Every measure from this source
5 years, by the period each figure describes
Sharp changes
0 in all loaded history, strongest first
No sharp change of this kind in all loaded history.
The records
Newest first, by the day each became public
No records in all loaded history with these filters.